| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |